Literature DB >> 4985156

The metabolic fate of amphetamine in man and other species.

L G Dring, R L Smith, R T Williams.   

Abstract

1. The fate of [(14)C]amphetamine in man, rhesus monkey, greyhound, rat, rabbit, mouse and guinea pig has been studied. 2. In three men receiving orally 5mg each (about 0.07mg/kg), about 90% of the (14)C was excreted in the urine in 3-4 days. About 60-65% of the (14)C was excreted in 1 day, 30% as unchanged drug, 21% as total benzoic acid and 3% as 4-hydroxyamphetamine. 3. In two rhesus monkeys (dose 0.66mg/kg), the metabolites excreted in 24h were similar to those in man except that there was little 4-hydroxyamphetamine. 4. In greyhounds receiving 5mg/kg intraperitoneally the metabolites were similar in amount to those in man. 5. Rabbits receiving 10mg/kg orally differed from all other species. They excreted little unchanged amphetamine (4% of dose) and 4-hydroxyamphetamine (6%). They excreted in 24h mainly benzoic acid (total 25%), an acid-labile precursor of 1-phenylpropan-2-one (benzyl methyl ketone) (22%) and conjugated 1-phenylpropan-2-ol (benzylmethylcarbinol) (7%). 6. Rats receiving 10mg/kg orally also differed from other species. The main metabolite (60% of dose) was conjugated 4-hydroxyamphetamine. Minor metabolites were amphetamine (13%), N-acetylamphetamine (2%), norephedrine (0.3%) and 4-hydroxynorephedrine (0.3%). 7. The guinea pig receiving 5mg/kg excreted only benzoic acid and its conjugates (62%) and amphetamine (22%). 8. The mouse receiving 10mg/kg excreted amphetamine (33%), 4-hydroxyamphetamine (14%) and benzoic acid and its conjugates (31%). 9. Experiments on the precursor of 1-phenylpropan-2-one occurring in rabbit urine suggest that it might be the enol sulphate of the ketone. A very small amount of the ketone (1-3%) was also found in human and greyhound urine after acid hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4985156      PMCID: PMC1185381          DOI: 10.1042/bj1160425

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  THE EXCRETION OF DEXAMPHETAMINE AND ITS DERIVATIVES.

Authors:  A M ASATOOR; B R GALMAN; J R JOHNSON; M D MILNE
Journal:  Br J Pharmacol Chemother       Date:  1965-02

2.  Biochemical studies of toxic agents. 11. The occurrence of premercapturic acids.

Authors:  R H KNIGHT; L YOUNG
Journal:  Biochem J       Date:  1958-09       Impact factor: 3.857

3.  The enzymic synthesis of aryl sulphamates.

Authors:  A ROY
Journal:  Biochem J       Date:  1960-01       Impact factor: 3.857

4.  Studies in detoxication. 59. The metabolism of alkylbenzenes; the biological reduction of ketones derived from alkylbenzenes.

Authors:  J N SMITH; R H SMITHIES; R T WILLIAMS
Journal:  Biochem J       Date:  1954-05       Impact factor: 3.857

5.  Studies on sympathomimetic amines. II. The biotransformation and physiological disposition of d-amphetamine, d-p-hydroxyamphetamine and d-methamphetamine.

Authors:  J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1954-03       Impact factor: 4.030

6.  The quantitative determination of hippuric acid.

Authors:  G W GAFFNEY; K SCHREIER; N DIFERRANTE; K I ALTMAN
Journal:  J Biol Chem       Date:  1954-02       Impact factor: 5.157

7.  The separation and identification of some sympathomimetic amines by paper partition chromatography.

Authors:  A WICKSTROM; B SALVESEN
Journal:  J Pharm Pharmacol       Date:  1952-09       Impact factor: 3.765

8.  The conversion in vivo of D-amphetamine to (+)-p-hydroxynorephedrine.

Authors:  M Goldstein; B Anagnoste
Journal:  Biochim Biophys Acta       Date:  1965-08-24

9.  The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals.

Authors:  L L Iversen; J Glowinski; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1966-02       Impact factor: 4.030

10.  The central locomotor stimulatory acitivity and acute toxicity of the ephedrine and norephedrine isomers in mice.

Authors:  M D Fairchild; G A Alles
Journal:  J Pharmacol Exp Ther       Date:  1967-10       Impact factor: 4.030

View more
  34 in total

1.  Modification of the noradrenergic cyclic AMP generating system in the rat limbic forebrain by amphetamine: role of its hydroxylated metabolites.

Authors:  P L Mobley; E Sanders-Bush; H E Smith; F Sulser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-04       Impact factor: 3.000

2.  Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings.

Authors:  Mariana Cherner; Chad Bousman; Ian Everall; Daniel Barron; Scott Letendre; Florin Vaida; J Hampton Atkinson; Robert Heaton; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2010-08-23       Impact factor: 2.892

3.  Drug metabolism and pharmacogenetics: the British contribution to fields of international significance.

Authors:  John Caldwell
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

4.  Effect of ethanol on toxicity and metabolism of amphetamine in the mouse.

Authors:  F Iverson; B B Coldwell; R H Downie; L W Whitehouse
Journal:  Experientia       Date:  1975-06-15

Review 5.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

6.  Induction of the in vitro p-hydroxylation of 14C-amphetamine stereoisomers in phenobarbital-treated rats.

Authors:  P Medilanski; J Corthay; A Benakis
Journal:  Experientia       Date:  1977-07-15

Review 7.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

8.  Species differences in the metabolism of norephedrine in man, rabbit and rat.

Authors:  J E Sinsheimer; L G Dring; R T Williams
Journal:  Biochem J       Date:  1973-11       Impact factor: 3.857

Review 9.  Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.

Authors:  Tanya E Froehlich; James J McGough; Mark A Stein
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

Review 10.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.